U.S. cannabis consulting and management company MedMen is proud to announce a partnership with MedReleaf Corp. The partnership will bring MedMen to Canada to help further optimize MedReleaf’s operations with a specific focus on infused and extract product lines. Reciprocally, MedReleaf will be expanding into the U.S. where MedMen will manufacture and distribute MedReleaf’s premium products.
MedMen brings its operational expertise in cannabis cultivation and extraction to further enhance MedReleaf’s operations. MedReleaf services thousands of patients daily, a number that is only increasing as the industry continues to open up. MedMen will consult on extraction methodologies, manufacturing methodologies, cultivation methodologies, product development, packaging and marketing, and SOPs.
In addition to consulting services, MedMen will provide MedReleaf with a license to use MedMen’s proprietary tracking software. The software program is a seed-to-ship physical tracking system that constantly checks the vital signs of a macro-sized grow operation. It collects operation improvement data, provides long-term forecasting, resource planning, purchasing assistance, and full recall trace protection. The program handles cultivation, extraction, and production.
As part of the new agreement, MedMen will produce MedReleaf’s first-rate products to be sold in the US under MedMen’s client-operated facilities and the two leading organizations will seek to collaborate in other jurisdictions and markets.
“MedReleaf is the leading supplier in Canada and recognizes the importance of producing high-quality medical cannabis while maintaining industrial-level quality controls,” says Adam Bierman, CEO of MedMen. “We are very excited to combine our cultivation and extraction techniques with MedReleaf’s current operations to better serve the increasing demand.” MedReleaf CEO Neil Closner will join MedMen’s Board of Advisors effective immediately.
For more information
MedMen
Ada Lee
T: 310-299-7860310-299-7860
MedReleaf